Next Article in Journal
Identification of Differentially Expressed miRNAs between White and Black Hair Follicles by RNA-Sequencing in the Goat (Capra hircus)
Next Article in Special Issue
Gamma Knife Treatment of Brainstem Metastases
Previous Article in Journal
Evaluation of Zosteric Acid for Mitigating Biofilm Formation of Pseudomonas putida Isolated from a Membrane Bioreactor System
Previous Article in Special Issue
Brain Metastasis-Initiating Cells: Survival of the Fittest
Open AccessReview

Molecular Biology of Brain Metastasis

Department of Neurosurgery, Pennsylvania College of Osteopathic Medicine, 4170 City Ave. Office of Graduate Medical Education, Philadelphia, PA 19131, USA
Translational Genomics Research Institute, 445 North Fifth Street, Phoenix, AZ 85004, USA
Department of Neurosurgery, Geisinger Health System, 100 North Academy Ave., Danville, PA 17822, USA
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2014, 15(6), 9519-9530;
Received: 28 March 2014 / Revised: 17 April 2014 / Accepted: 9 May 2014 / Published: 28 May 2014
(This article belongs to the Special Issue Brain Metastasis 2014)
Metastasis to the central nervous system (CNS) remains a major cause of morbidity and mortality in patients with systemic cancer. As the length of survival in patients with systemic cancer improves, thanks to multimodality therapies, focusing on metastases to the CNS becomes of paramount importance. Unique interactions between the brain’s micro-environment, blood-brain barrier, and tumor cells are hypothesized to promote distinct molecular features in CNS metastases that may require tailored therapeutic approaches. This review will focus on the pathophysiology, epigenetics, and immunobiology of brain metastases in order to understand the metastatic cascade. Cancer cells escape the primary tumor, intravasate into blood vessels, survive the hematogenous dissemination to the CNS, arrest in brain capillaries, extravasate, proliferate, and develop angiogenic abilities to establish metastases. Molecular biology, genetics, and epigenetics are rapidly expanding, enabling us to advance our knowledge of the underlying mechanisms involved. Research approaches using cell lines that preferentially metastasize in vivo to the brain and in vitro tissue-based studies unfold new molecular leads into the disease. It is important to identify and understand the molecular pathways of the metastatic cascade in order to target the investigation and development of more effective therapies and research directions. View Full-Text
Keywords: epigenetics; tumor immunology; animal models; signal transduction epigenetics; tumor immunology; animal models; signal transduction
Show Figures

Figure 1

MDPI and ACS Style

Svokos, K.A.; Salhia, B.; Toms, S.A. Molecular Biology of Brain Metastasis. Int. J. Mol. Sci. 2014, 15, 9519-9530.

AMA Style

Svokos KA, Salhia B, Toms SA. Molecular Biology of Brain Metastasis. International Journal of Molecular Sciences. 2014; 15(6):9519-9530.

Chicago/Turabian Style

Svokos, Konstantina A.; Salhia, Bodour; Toms, Steven A. 2014. "Molecular Biology of Brain Metastasis" Int. J. Mol. Sci. 15, no. 6: 9519-9530.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop